Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 14, 2006; 12(26): 4181-4184
Published online Jul 14, 2006. doi: 10.3748/wjg.v12.i26.4181
Figure 1
Figure 1 Ductal adenocarcinoma. A: US showing slightly hypoechoic pancreatic head mass (asterisk); B: CEUS showing poor enhancement of the mass, appearing hypoechoic to the rest of pancreatic parenchyma in the contrast-enhanced phases.
Figure 2
Figure 2 Mass-forming chronic autoimmune pancreatitis. A: US showing hypoechoic head pancreatic mass (asterisk); B: CEUS showing parenchymographic enhancement of the pancreatic lesion in the head of the pancreas during the contrast-enhanced phases.
Figure 3
Figure 3 Receiver operating characteristic curves of baseline ultrasound and contrast-enhanced ultrasound in the characterization of 173 pancreatic masses, discerning between benignancy (pancreatitis) and malignancy (tumor).